{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:18:50Z","timestamp":1792289930836,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2107,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009431","name":"Baxalta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/jth.13571","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T02:18:41Z","timestamp":1479694721000},"page":"312-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":448,"title":["Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies"],"prefix":"10.1016","volume":"15","author":[{"given":"M.","family":"Scully","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cataland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de la Rubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kremer Hovinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"L\u00e4mmle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pavenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sarode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Scharrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Veyradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13571_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jca.21302","article-title":"Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research","volume":"29","author":"Sarode","year":"2014","journal-title":"J Clin Apher"},{"key":"10.1111\/jth.13571_bb0015","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor\u2010cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"10.1111\/jth.13571_bb0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2010cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13571_bb0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/s-0033-1343894","article-title":"Sepsis and thrombosis","volume":"39","author":"Levi","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13571_bb0030","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.molimm.2009.05.018","article-title":"Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: indications for a disease spectrum and common pathogenic principles","volume":"46","author":"Skerka","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1111\/jth.13571_bb0035","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/jth.13571_bb0040","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1309\/LM72AM5XFHZYOQCB","article-title":"Scleroderma renal crisis or thrombotic thrombocytopenic purpura: seeing through the masquerade","volume":"46","author":"Keeler","year":"2015","journal-title":"Lab Med"},{"key":"10.1111\/jth.13571_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9343(86)90201-9","article-title":"Rocky Mountain spotted fever presenting as thrombotic thrombocytopenic purpura","volume":"81","author":"Turner","year":"1986","journal-title":"Am J Med"},{"key":"10.1111\/jth.13571_bb0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer","volume":"12","author":"Morton","year":"2016","journal-title":"J Oncol Pract"},{"key":"10.1111\/jth.13571_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2141.2005.05837.x","article-title":"Reseau d'Etude des Microangiopathies Thrombotiques de lA. Prognostic value of inhibitory anti\u2010ADAMTS\u201013 antibodies in adult\u2010acquired thrombotic thrombocytopenic purpura","volume":"132","author":"Coppo","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2006-939764","article-title":"Thrombotic thrombocytopenic purpura associated with von Willebrand factor\u2010cleaving protease (ADAMTS\u201013) deficiency in children","volume":"32","author":"Loirat","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13571_bb0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mpd.2003.79","article-title":"Severe deficiency of the specific von Willebrand factor\u2010cleaving protease (ADAMTS\u201013) activity in a subgroup of children with atypical hemolytic uremic syndrome","volume":"142","author":"Veyradier","year":"2003","journal-title":"J Pediatr"},{"key":"10.1111\/jth.13571_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/trf.12762","article-title":"Diagnostic and prognostic values of ADAMTS\u201013 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura","volume":"55","author":"Wu","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1111\/jth.13571_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2008.07107.x","article-title":"Relationship between ADAMTS\u201013 activity in clinical remission and the risk of TTP relapse","volume":"141","author":"Jin","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse","volume":"11","author":"Westwood","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2006.06448.x","article-title":"Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS\u201013","volume":"136","author":"Scully","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood-2014-01-550244","article-title":"Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura","volume":"124","author":"Hie","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13571_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.21143","article-title":"ADAMTS\u201013 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura","volume":"31","author":"Lotta","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1111\/jth.13571_bb0105","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","article-title":"Mutations and common polymorphisms in ADAMTS\u201013 gene responsible for von Willebrand factor\u2010cleaving protease activity","volume":"99","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13571_bb0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1111\/jth.13571_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","article-title":"Natural history of Upshaw\u2013Schulman syndrome based on ADAMTS\u201013 gene analysis in Japan","volume":"9","author":"Fujimura","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mbc.0000240918.65306.20","article-title":"Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura","volume":"17","author":"Scully","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13571_bb0125","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw\u2013Schulman syndrome in pregnancy\u2010onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti\u2010Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13571_bb0130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1160\/TH13-08-0713","article-title":"The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications","volume":"111","author":"von Krogh","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614408","article-title":"Recovery and half\u2010life of von Willebrand factor\u2010cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura","volume":"81","author":"Furlan","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2009.03692.x","article-title":"Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link","volume":"8","author":"Scully","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2011.08636.x","article-title":"Human immunodeficiency virus associated thrombotic thrombocytopenic purpura \u2013 favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy","volume":"153","author":"Hart","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0150","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(05)70492-X","article-title":"Thrombotic thrombocytopenic purpura and simvastatin","volume":"352","author":"McCarthy","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/jth.13571_bb0155","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/MBC.0b013e32834a6170","article-title":"Thrombotic thrombocytopenic purpura associated with statin therapy","volume":"22","author":"Thomas","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13571_bb0160","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ajh.20887","article-title":"Thrombotic thrombocytopenic purpura induced by trimethoprim\u2010sulfamethoxazole in a Jehovah's Witness","volume":"82","author":"Martin","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13571_bb0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gcb.2007.12.019","article-title":"Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis","volume":"32","author":"Sallee","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1111\/jth.13571_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000001598","article-title":"Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura","volume":"94","author":"Roriz","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/jth.13571_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s100670200013","article-title":"Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjogren's syndrome","volume":"21","author":"Schattner","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1111\/jth.13571_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2008.02143.x","article-title":"Human immunodeficiency virus\u2010associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS\u201013 activity","volume":"68","author":"Malak","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1111\/jth.13571_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case\u2010control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"key":"10.1111\/jth.13571_bb0190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.transci.2016.04.011","article-title":"Defining the genetics of thrombotic microangiopathies","volume":"54","author":"Vieira\u2010Martins","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1111\/jth.13571_bb0195","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0030-1262885","article-title":"Anti\u2010factor H autoantibody\u2010associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS","volume":"36","author":"Dragon\u2010Durey","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13571_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic\u2010uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1111\/jth.13571_bb0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jth.13571_bb0210","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2010uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13571_bb0215","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13571_bb0220","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea\u2010negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/jth.13571_bb0225","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12185-016-2019-x","article-title":"Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy","volume":"104","author":"Miyakawa","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1111\/jth.13571_bb0230","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/trf.13229","article-title":"Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study","volume":"55","author":"Toussaint\u2010Hacquard","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1111\/jth.13571_bb0235","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13571_bb0240","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS\u201013 and anti\u2010ADAMTS\u201013 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jth.13571_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13571_bb0250","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/beha.2001.0142","article-title":"Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor\u2010cleaving protease","volume":"14","author":"Furlan","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/jth.13571_bb0255","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Development and validation of a predictive model for death in acquired severe ADAMTS\u201013 deficiency\u2010associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"key":"10.1111\/jth.13571_bb0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2009.03285.x","article-title":"Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS\u201013","volume":"7","author":"Hughes","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1600-0609.2009.01331.x","article-title":"Demographic and ADAMTS\u201013 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura","volume":"83","author":"Cataland","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.13571_bb0270","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti\u2010ADAMTS\u201013 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1111\/jth.13571_bb0275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS\u2010VWF73, a first fluorogenic substrate for ADAMTS\u201013 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0280","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody\u2010based enzyme immunoassay for determining plasma levels of ADAMTS\u201013 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion (Paris)"},{"key":"10.1111\/jth.13571_bb0285","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/jth.12319","article-title":"An optimized fluorogenic ADAMTS\u201013 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura","volume":"11","author":"Muia","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0290","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1538-7836.2006.01758.x","article-title":"A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption\/ionization time\u2010of\u2010flight (SELDI\u2010TOF)\u2010mass spectrometry","volume":"4","author":"Jin","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0295","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jth.12881","article-title":"Establishment of the WHO 1st International Standard ADAMTS\u201013, plasma (12\/252): communication from the SSC of the ISTH","volume":"13","author":"Hubbard","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0300","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1538-7836.2010.03761.x","article-title":"ADAMTS\u201013 assays in thrombotic thrombocytopenic purpura","volume":"8","author":"Peyvandi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0305","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1538-7836.2007.02438.x","article-title":"Hyperbilirubinemia interferes with ADAMTS\u201013 activity measurement by FRETS\u2010VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies","volume":"5","author":"Meyer","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0310","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.13571_bb0315","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH12-08-0565","article-title":"Discrepancies between ADAMTS\u201013 activity assays in patients with thrombotic microangiopathies","volume":"109","author":"Mackie","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13571_bb0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOP.0b013e32835d7f2c","article-title":"Update on Streptococcus pneumoniae associated hemolytic uremic syndrome","volume":"25","author":"Spinale","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1111\/jth.13571_bb0325","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-007-0604-1","article-title":"Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder","volume":"22","author":"Sharma","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/jth.13571_bb0330","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant\u2010associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/jth.13571_bb0335","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation\u2010associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/jth.13571_bb0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0345","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"key":"10.1111\/jth.13571_bb0350","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0002-9378(99)70022-0","article-title":"The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification","volume":"180","author":"Martin","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jth.13571_bb0355","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2008.613","article-title":"Ticlopidine\u2010 and clopidogrel\u2010associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989\u20132008)","volume":"112","author":"Zakarija","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1111\/jth.13571_bb0360","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7326\/0003-4819-135-12-200112180-00008","article-title":"Quinine\u2010associated thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome: frequency, clinical features, and long\u2010term outcomes","volume":"135","author":"Kojouri","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.13571_bb0365","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13571_bb0370","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2141.2008.07458.x","article-title":"Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry","volume":"144","author":"McDonald","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13571_bb0375","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3324\/haematol.10963","article-title":"Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura\u2010hemolytic uremic syndrome: report of five patients with a systematic review of published reports","volume":"92","author":"Swisher","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/jth.13571_bb0380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","article-title":"Cancer\u2010related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases","volume":"91","author":"Lechner","year":"2012","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13571","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13571","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.13571","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622032500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622032500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:18:38Z","timestamp":1761535118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622032500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1538783622032500"],"URL":"https:\/\/doi.org\/10.1111\/jth.13571","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}